Cited by 1,065Celiac Disease Research and ManagementWheat and Barley Genetics and PathologyEosinophilic Esophagitis

Coeliac disease

Lebwohl, Benjamin, Sanders, David S, Green, Peter H R·2018·The Lancet

Abstract

Coeliac disease occurs in about 1% of people in most populations. Diagnosis rates are increasing, and this seems to be due to a true rise in incidence rather than increased awareness and detection. Coeliac disease develops in genetically susceptible individuals who, in response to unknown environmental factors, develop an immune response that is subsequently triggered by the ingestion of gluten. The disease has many clinical manifestations, ranging from severe malabsorption to minimally symptomatic or non-symptomatic presentations. Diagnosis requires the presence of duodenal villous atrophy, and most patients have circulating antibodies against tissue transglutaminase; in children, European guidelines allow a diagnosis without a duodenal biopsy provided that strict symptomatic and serological criteria are met. Although a gluten-free diet is an effective treatment in most individuals, a substantial minority develop persistent or recurrent symptoms. Difficulties adhering to a gluten-free diet have led to the development of non-dietary therapies, several of which are undergoing trials in human beings.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(17)31796-8

Cites

142 of 142 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

1 of the 143 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Lebwohl, B., Sanders, D. S., & Green, P. H. R.
Affiliations
  • Columbia University Irving Medical Center (US)
  • Royal Hallamshire Hospital (GB)
Corresponding author
Green, Peter H R
Venue
The Lancet
Publisher
Elsevier BV
Published
2018-01
Volume
391
Issue
10115
Pages
70-81
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W4211144941
Cited by
1,065
References
143
Citations by year
2026: 98 · 2025: 101 · 2024: 138 · 2023: 115 · 2022: 142 · 2021: 177 · 2020: 144 · 2019: 90 · 2018: 58 · 2017: 2
FWCI
13.52
Type
journal article
Language
en
Open access
closed
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Celiac Disease Research and Management
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Wheat and Barley Genetics and Pathology
  • Health Sciences › Medicine › Surgery › Eosinophilic Esophagitis
Keywords
celiac disease, gluten, duodenal villous atrophy, anti-tissue transglutaminase antibodies, serological diagnosis, duodenal biopsy, gluten-free diet, malabsorption, incidence, genetic susceptibility, environmental triggers
MeSH terms
Celiac Disease, Humans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review